Bayer Submits SNDA For Expanded Use Of NUBEQA In Metastatic Hormone-Sensitive Prostate Cancer To FDA

RTTNews | 22 dias atrás
Bayer Submits SNDA For Expanded Use Of NUBEQA In Metastatic Hormone-Sensitive Prostate Cancer To FDA

(RTTNews) - German pharmaceutical company Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Thursday the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for the oral androgen receptor inhibitor (ARi) NUBEQA (darolutamide) in combination with androgen deprivation therapy (ADT) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC).

The submission is based on positive results from the investigational pivotal Phase III ARANOTE trial that showed NUBEQA plus ADT demonstrated an improvement in radiological progression-free survival (rPFS), significantly reducing in the risk of progression or death in patients with mHSPC compared to placebo plus ADT.

NUBEQA is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.

NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC).

read more
Bayer Stock Climbs On US Legal Win In Roundup Cancer Claims

Bayer Stock Climbs On US Legal Win In Roundup Cancer Claims

Shares of Bayer AG were climbing around 11 percent in German trading after the pharmaceutical and life sciences major announced a favorable ruling in the United States in the lawsuit over cancer claims against its Roundup weed killer. In a statement, the company noted that the Third Circuit Court of Appeals issued its favorable ruling in Schaffner v. Monsanto...
RTTNews | 63 dias atrás
Bayer Q4 Profit Surges, Warns On FY24; Says Break-up Not Now

Bayer Q4 Profit Surges, Warns On FY24; Says Break-up Not Now

German pharmaceutical and biotechnology major Bayer AG reported Tuesday a surge in its fourth-quarter net profit benefited by weak expenses. Meanwhile, sales were hurt by lower Pharmaceuticals sales, despite growth in Crop Science and consumer Health segments. Further, the company trimmed its dividend, and said it sees lower adjusted earnings and nearly flat sales in fiscal 2024 on a currency-adju
RTTNews | 228 dias atrás
Bayer's Mirena Gets Approval In Europe For Extended Duration Of Use In Contraception

Bayer's Mirena Gets Approval In Europe For Extended Duration Of Use In Contraception

German pharmaceutical company Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Friday that Mirena (52mg LNG IUS), its long-acting reversible intrauterine system, received regulatory approval in the European Workshare Procedure for up to eight years in contraception. This is the longest contraceptive duration of use for any hormonal intrauterine system.
RTTNews | 735 dias atrás
TSX Continues To Move Up North, Ends 0.53% Up At New High

TSX Continues To Move Up North, Ends 0.53% Up At New High

The Canadian market climbed to a new record high on Friday, rising for a third straight day, thanks to strong gains in materials stocks as metal prices surged to record highs. Continued optimism about interest rate cuts by the Bank of Canada also aided sentiment.
RTTNews | 13h 0min atrás
Dollar Turns Weak After Recent Gains

Dollar Turns Weak After Recent Gains

The U.S. dollar turned a bit weak on Friday, snapping a five-day winning streak, with global stocks moving higher on increased risk appetite after the Chinese government announced a couple of funding schemes.
RTTNews | 13h 38min atrás
TSX Rises To New High; Materials Shares Rally

TSX Rises To New High; Materials Shares Rally

The Canadian market is up firmly in positive territory Friday afternoon after posting a new high for the third straight day. Materials stocks are contributing to the move up north, with firm metal prices triggering hectic buying at several counters in the sector.
RTTNews | 17h 2min atrás
Canadian Dollar Weakens As Oil Prices Fall

Canadian Dollar Weakens As Oil Prices Fall

The Canadian dollar declined against its most major counterparts in the New York session on Friday, as oil prices dropped on concerns about slowing demand from China.
RTTNews | 17h 20min atrás
Swiss Market Closes Modestly Higher

Swiss Market Closes Modestly Higher

The Switzerland market ended modestly higher on Friday after a choppy ride as investors looked ahead to more interest rate cuts from central banks after the European Central Bank cut rates for the third time this year.
RTTNews | 17h 28min atrás